A3P Biomedical
A3P Biomedical is a Swedish medical technology company that develops diagnostic tests for early detection of prostate cancer. The company's solutions are based on advanced biomarker analysis and aim to improve the accuracy of diagnostics compared to traditional methods such as PSA testing. By combining high clinical precision with ease of use, A3P Biomedical helps to reduce unnecessary biopsies and misdiagnosis. The company's tests are developed to be used as a complement in the clinical decision-making process and are primarily aimed at healthcare providers in urology and oncology.
Trade in A3P Biomedical

